LGND 营收历史(2016–2025)
LIGAND PHARMACEUTICALS INCORPORATED (LGND) 年度营收历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
$268.1MFY2025 · FY2016 以来:$109.0M → $268.1M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $268.1M | +60.4% |
| FY2024 | $167.1M | +27.3% |
| FY2023 | $131.3M | -33.1% |
| FY2022 | $196.2M | -18.8% |
| FY2021 | $241.5M | +47.7% |
| FY2020 | $163.6M | +36.0% |
| FY2019 | $120.3M | -52.2% |
| FY2018 | $251.5M | +78.2% |
| FY2017 | $141.1M | +29.5% |
| FY2016 | $109.0M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议